Renal Cancer News and Research

RSS
Marker identified for population of renal cancer cells with stem-cell-like features

Marker identified for population of renal cancer cells with stem-cell-like features

Marker identified for population of renal cancer cells with stem-cell-like features

Marker identified for population of renal cancer cells with stem-cell-like features

Targeting CXCR4–CXCL12–CXCR7 axis combats mTOR inhibitor resistance in renal cancer

Targeting CXCR4–CXCL12–CXCR7 axis combats mTOR inhibitor resistance in renal cancer

A personalized approach for patients with ccRCC-related mutations

A personalized approach for patients with ccRCC-related mutations

Protein may predict outcome of targeted mccRCC therapy

Protein may predict outcome of targeted mccRCC therapy

Reduced glomerular filtration rate is independent risk factor for renal and urothelial cancer

Reduced glomerular filtration rate is independent risk factor for renal and urothelial cancer

Novel bioinformatics approach suggests antimicrobial drug may help in treating advanced kidney cancer

Novel bioinformatics approach suggests antimicrobial drug may help in treating advanced kidney cancer

Study: Honokiol reduces proliferation of renal cell carcinoma

Study: Honokiol reduces proliferation of renal cell carcinoma

Vaccine targeting tumors could initiate immune response to fight cancer

Vaccine targeting tumors could initiate immune response to fight cancer

Partial nephrectomy may offer younger renal cancer patients survival advantage

Partial nephrectomy may offer younger renal cancer patients survival advantage

Response of brain tumors from SRS can indicate necessity of follow-up treatments

Response of brain tumors from SRS can indicate necessity of follow-up treatments

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies closes €34 million Series D financing round

Amendment to renal cancer TNM staging proposed

Amendment to renal cancer TNM staging proposed

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Possible alternative to biopsy discovered for renal cancer diagnosis

Possible alternative to biopsy discovered for renal cancer diagnosis

TIR-199 shows promise in fighting renal cancer

TIR-199 shows promise in fighting renal cancer

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer